Compound Tirzepatide 60mg (with free injection pen and needle)

What Are GLP-1 Medications (Semaglutide, Tirzepatide)? GLP-1 medications are a class of prescription drugs that not only improves blood sugar control but may also lead to weight loss. This class of drugs is commonly called glucagon-like peptide 1 (GLP-1) agonists. Weight loss can vary, depending on which GLP-1 drug you use and the dosage. Studies found people using Semaglutide and making lifestyle changes lost about 33.7 pounds (15.3 kilograms) versus 5.7 pounds (2.6 kilograms) in those who didn’t use the drug. GLP-1 medications are generally taken by an injection given weekly, depending on the drug (Semaglutide, Tirzepatide). How does Semaglutide it work? Semaglutide is a newer injectable drug approved by the Food and Drug Administration (FDA) to help obese adults lose weight and keep it off. Semaglutide weight loss works through GLP-1 agonism, or the stimulation of glucagon-like peptide 1 receptors in your intestines. When these receptors are activated, your body experiences a drop in appetite as well as an increase in blood sugar, among other things. Semaglutide is different from other weight loss treatments out there because of how it is administered and the fact that it is FDA approved. Semaglutide must be injected subcutaneously. It was also found to improve blood sugar in people with type 2 diabetes and can help control blood sugar in combination with other diabetes treatment you may be using, like sulfonylurea or insulin. Semaglutide is not used as an anti-diabetic medicine on its own but rather along with these other drugs to help manage your blood sugar. Because semaglutide works by manipulating your body’s GLP-1 levels, it isn’t able to give you any immediate effects after taking it, meaning that you won’t feel satisfied until a few hours later when its effects start working on your system. This may take some getting used to if you are transitioning off fast-acting diet pills or something similar. Is Semaglutide (GLP-1) approved for weight loss? Semaglutide, FDA-approved medications containing the active ingredient semaglutide, are designed for weight management. When should I take my dose of Semaglutide/Tirzepatide? You can inject GLP-1 medications at any time during the day, without regard to meals. If your dosage is prescribed to inject weekly, you should inject your dose on the same day each week. What's the difference between a GLP-1 medication and other weight loss medications? GLP-1 receptor agonists, which are commonly referred to as GLP-1s, work by stimulating the hormone GLP-1. This leads to secretion of insulin (which lowers the levels of glucose in the body) and also slows the emptying of the stomach, which keeps people feeling full longer. Synthetic GLP-1 analogs, like the compounds in GLP-1 medications, also have a longer half-life in the body compared to the naturally occurring version. Other classes of weight loss medications all have unique mechanisms of action that do not necessarily affect the GLP-1 pathway. For example, naltrexone; bupropion is a combination of two drugs, naltrexone and bupropion, that together can help reduce cravings and appetite by acting on the brain and nervous system. Adverse effects As with other GLP-1 (glucagon-like peptide 1) receptor agonists, adverse effects GLP effects are common (~5%); the major adverse effects are gastrointestinal, including nausea, diarrhea, and vomiting. In weight loss trials, these adverse effects were generally mild to moderate and, for most patients, improved over time. Who should not take GLP-1 prescription weight loss medication? Who should not take GLP-1 prescription weight loss medication? You may not be eligible for a GLP-1 prescription if you meet any of the following criteria: *Under the age of 18 or above the age of 74 *BMI<27 *Currently pregnant or actively trying to become pregnant *Breastfeeding or providing bottled breastmilk *Active eating disorder or history of eating disorder (bulimia, anorexia, etc.) *Active cancer diagnosis or treatment, or in remission or cancer-free for less than 5 continuous years *Active suicidal thoughts or past suicide attempts *History of organ transplant on anti-rejection therapy *Heart attack or stroke within the last 12 months *Severe gastrointestinal diseases such as gastroparesis, blockages, or inflammatory bowel disease *End stage kidney disease (also called end-stage renal disease) *End stage liver disease (cirrhosis) *Pancreatitis *Family or personal history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2) *Type 1 diabetes or type 2 diabetes treated with insulin *Diabetic retinopathy